I. COMMENCED TRADING IN DECEMBER

Company (Symbol)

Date Filed

Date Comm.

Shares/Units

Price

Shares Out (M)

Lead, Other Underwriters#

Gross ($M)

Net ($M)

INITIAL OFFERINGS

Maxygen Inc. (MAXY)

11/20

12/22

6.9S

$16

29.9

GS, RS, IA

$110.4

$102

FOLLOW-ON OFFERINGS

Inex Pharmaceuticals Corp.1 (TSE:IEX)

10/18

11/23

4.9S

C$3.75 (US$2.55)

ND

NB,RBC, YS

C$18.5 (US$12.6)

C$17.6E (US$12E)

Progenics Pharmaceuticals Inc.2 (PGNX)

10/13

11/19

2.3S

$19

11.6

CIBC, RS, PVH, GKMC, PZC

$43.7E

$41.1

Notes:

# See Underwriters' Key on page 4.

1 Inex's underwriters exercised their overallotment option on 12/10 for 0.4M shares at C$3.75 (US$2.55) per share, raising gross proceeds of approximately C$1.4M (US$0.95M), bringing total gross proceeds of the offering to approximately $18.5M (US$12.6M).

2 Progenics' underwriters exercised their overallotment option on 12/1 for 0.3M shares at $19 per share, raising net proceeds of approximately $5.4M, bringing total net proceeds of the offering to approximately $41.1M.

Company (Symbol)

Date Filed

Shares/Units (M)

Price Range

Shares Out (M)

Lead, Other UWs

Value (M)

INITIAL OFFERINGS

Antigenics LLC1

11/30

ND

ND

ND

USBPJ, RS

$46

Diversa Corp.2

12/16

ND

ND

ND

BSC, HQ

­

Sequenom Inc.3

11/24

ND

ND

ND

WDR, RS, SGC

­

Tularik Inc.4

10/15

6.25S

ND

41.4

LBI, HQ, JPM, WDR

­

FOLLOW-ON OFFERINGS

Vical Inc.5

12/16

2.875S

$20.66

ND

GS, RS, SGC, FUS

$59.4E

Notes:

1 Antigenics' prospectus leaves blank the number of shares offered, the share price and the number of shares outstanding.

2 Diversa's prospectus leaves blank the number of shares offered, the share price and the number of shares outstanding.

3 Sequenom's prospectus leaves blank the number of shares offered, the share price and the number of shares outstanding.

4 Tularik's prospectus leaves blank the share price.

5 The registered amount of 2.875M shares includes 0.375M shares to cover the overallotment option granted by Vical to the underwriters. The registered share price of $20.66 is estimated solely for the purpose of calculating the registration fee.

OTHER NOTES:

E 3D estimated; ND 3D not disclosed, reported and/or available; S 3D shares; U 3D units; W 3D warrants

"Date filed" indicates the date on which the company announced that it had filed a preliminary prospectus with the Securities and Exchange Commission for its offering. It is not necessarily the same date as that which is printed on the preliminary prospectus itself.

In completed offerings, the number of shares sold includes the overallotment (in full or in part) if that option has been exercised by the time this publication goes to press.

Shares outstanding refers to the number of shares outstanding after the public offering. In the case of those offerings that are still pending, it assumes that the number of shares sold in the offering will be equal to the number intended for sale as per the prospectus.

Unless otherwise indicated, the stock symbols listed are on the Nasdaq Market.

NYSE 3D New York Stock Exchange; TSE 3D Toronto Stock Exchange

Conversion rate of C$1 3D US$0.68